PS.
PublicSupply

NHS National Framework Agreement for the Supply of products for the management of Hereditary Angioedema

NHS EnglandcontractFind a Tender ↗Ref ocds-h6vhtk-0314ad32014L0024active
View buyer

Estimated value

—

goods

Awarded value

—

Suppliers

14

4 SME

Lots

7

11 awarded

Published

19 Jul 2022

Total lots

7

Awarded

5

2 pending

Estimated total

—

Awarded total

—

Lot 1cancelled

Lot 1 – C1 Esterase – Recombinant IV (acute treatment)

Estimated
—

Start

—

End

—

Estimated

—

CPV

33600000
No suppliers awarded yet for this lot.
Lot 3cancelled

Lot 3 - C1 Esterase – Plasma derived IV (prophylaxis treatment)

Award value
—

Start

—

End

—

Estimated

—

CPV

33600000
Awarded to 1 supplier
TU
Takeda UK Ltd
Lot 6cancelled

Lot 6 - Lanadelumab

Award value
—

Start

—

End

—

Estimated

—

CPV

33600000
Awarded to 1 supplier
TU
Takeda UK Ltd
Lot 7cancelled

Lot 7 - Berotralstat

Award value
—

Start

—

End

—

Estimated

—

CPV

33600000
Awarded to 1 supplier
BI
BioCryst Ireland Limited
SME
Lot 2cancelled

Lot 2 - C1 Esterase – Plasma derived IV (acute treatment)

Estimated
—

Start

—

End

—

Estimated

—

CPV

33600000
No suppliers awarded yet for this lot.
Lot 4cancelled

Lot 4 - C1 Esterase – Plasma derived Subcut (prophylaxis treatment)

Award value
—

Start

—

End

—

Estimated

—

CPV

33600000
Awarded to 1 supplier
CB
CSL Behring UK Ltd
Lot 5cancelled

Lot 5 - Icatibant

Award value
—

Start

—

End

—

Estimated

—

CPV

33600000